What is the recommended evaluation and management of a complicated urinary tract infection in adult males?

Management of Complicated Urinary Tract Infections in Adult Males

All UTIs in adult males are classified as complicated UTIs by definition, requiring urine culture before treatment, 14 days of antimicrobial therapy (to exclude prostatitis), and mandatory evaluation for underlying urological abnormalities. 1

Initial Evaluation and Diagnostic Approach

Mandatory Pre-Treatment Steps

• Obtain urine culture and susceptibility testing before initiating antimicrobial therapy in all male patients with UTI symptoms 1
• Dipstick testing has poor diagnostic accuracy in males (sensitivity 54% for leukocytes, 38% for nitrite) and should not guide treatment decisions 2
• A negative urinalysis effectively rules out UTI in patients with functioning bone marrow, but positive results require culture confirmation 3

Identify Complicating Factors

The following factors commonly complicate UTIs in males and influence management 1:

• Urological abnormalities: obstruction at any urinary tract site, incomplete voiding, vesicoureteral reflux
• Foreign bodies: indwelling catheters, stents
• Host factors: diabetes mellitus, immunosuppression, recent instrumentation
• Microbial factors: ESBL-producing organisms, multidrug-resistant pathogens, healthcare-associated infections

Expected Microbiology

Males with complicated UTIs harbor a broader microbial spectrum with higher antimicrobial resistance rates compared to uncomplicated infections 1. Common pathogens include:

• E. coli, Proteus spp., Klebsiella spp., Pseudomonas spp., Serratia spp., and Enterococcus spp. 1
• Resistance rates in males: 53% for amoxicillin/cefaclor, 28% for cefixime, 22% for ciprofloxacin, 34% for trimethoprim-sulfamethoxazole 2

Empirical Antimicrobial Treatment

For Patients with Systemic Symptoms (Fever, Sepsis)

Use combination intravenous therapy as first-line empirical treatment 1:

• Amoxicillin plus an aminoglycoside (gentamicin 5 mg/kg daily or amikacin 15 mg/kg daily), OR
• Second-generation cephalosporin plus an aminoglycoside, OR
• Third-generation cephalosporin monotherapy (ceftriaxone 1-2 g daily or cefotaxime 2 g three times daily)

Fluoroquinolone Restrictions

Only use ciprofloxacin if ALL of the following criteria are met 1:

• Local resistance rate is <10%
• Entire treatment can be given orally
• Patient does not require hospitalization
• Patient has anaphylaxis to β-lactam antimicrobials

Do NOT use fluoroquinolones empirically if 1:

• Patient is from a urology department
• Patient has used fluoroquinolones in the last 6 months

For Multidrug-Resistant Organisms

Reserve broad-spectrum agents only for patients with early culture results confirming multidrug resistance 1:

• Meropenem 1 g three times daily
• Ceftolozane/tazobactam 1.5 g three times daily
• Ceftazidime/avibactam 2.5 g three times daily
• Cefiderocol 2 g three times daily

Treatment Duration

Treat for 14 days in all males to exclude occult prostatitis 1. This is a critical distinction from female patients with complicated UTIs.

Exception for Shorter Duration

Consider 7 days only when 1:

• Patient is hemodynamically stable
• Patient has been afebrile for at least 48 hours
• Relative contraindications exist to the prescribed antibiotic
• Treatment of the underlying abnormality has been successful

Tailoring Therapy

After Culture Results

• Switch from empirical intravenous therapy to oral antimicrobials based on susceptibility results 1
• De-escalate from broad-spectrum to narrow-spectrum agents when possible 4
• Adjust therapy according to local resistance patterns and specific host factors (allergies, renal function) 1

Managing Underlying Abnormalities

Correction of urological abnormalities is mandatory and equally important as antimicrobial therapy 1. Without addressing the underlying cause:

• Early post-treatment recurrence is anticipated 5
• Infection outcomes are principally determined by the underlying abnormality rather than the infection itself 5
• Treatment duration should be closely related to management of the underlying abnormality 1

Common Pitfalls to Avoid

Do Not Treat Empirically Without Culture

Unlike uncomplicated cystitis in women, males with UTI symptoms should never receive empirical treatment without obtaining urine culture first 2. Low-count bacteriuria (colony counts below traditional thresholds) is common in males and should not be dismissed as normal 2.

Do Not Assess Post-Treatment Asymptomatic Bacteriuria

• Routine post-treatment urinalysis or cultures are not indicated for asymptomatic patients 1, 4
• Post-treatment asymptomatic bacteriuria should not be treated 4

Do Not Use Single-Agent Aminoglycosides

Aminoglycosides have not been studied as monotherapy for complicated UTIs and should be used in combination regimens 1

Special Considerations

Catheter-Associated UTIs

If the male patient has an indwelling catheter or had one within 48 hours 1:

• Catheter-associated UTIs carry approximately 10% mortality risk from secondary bacteremia 1
• Catheterization duration is the most important risk factor (3-8% daily incidence of bacteriuria) 1
• Urine cultures are unreliable as bacteriuria is almost always present regardless of symptoms 3
• Clinical diagnosis relies on new fever, rigors, altered mental status, flank pain, or pelvic discomfort 1

When Symptoms Persist or Recur

For patients whose symptoms do not resolve or recur within 4 weeks after treatment completion 1:

• Repeat urine culture and susceptibility testing
• Assume the organism is not susceptible to the originally used agent
• Consider 14-day retreatment with an alternative agent based on culture results